Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13)

Authors

  • M. Patrizia Carrieri Ph.D.,

    1. INSERM, U912 (SESSTIM), Marseille, France
    2. Université Aix Marseille, IRD, UMR-S912, Marseille, France
    3. ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille, France
    Search for more papers by this author
  • Philippe Sogni M.D.,

    1. Institut Cochin, Université Paris-Descartes, INSERM U567-CNRS (UMR 8104), Paris, France
    2. APHP, Hôpital Cochin, Service d'Hépatologie, Paris
    Search for more papers by this author
  • Julien Cohen M.D.,

    1. INSERM, U912 (SESSTIM), Marseille, France
    2. Université Aix Marseille, IRD, UMR-S912, Marseille, France
    3. ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille, France
    Search for more papers by this author
  • Marc-Arthur Loko M.D.,

    1. University of Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France
    2. INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France
    Search for more papers by this author
  • Maria Winnock Ph.D.,

    1. University of Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France
    2. INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France
    Search for more papers by this author
  • Bruno Spire M.D., Ph.D.,

    1. INSERM, U912 (SESSTIM), Marseille, France
    2. Université Aix Marseille, IRD, UMR-S912, Marseille, France
    3. ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille, France
    Search for more papers by this author
  • and the HEPAVIH Study Group

    1. INSERM, U912 (SESSTIM), Marseille, France
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary